Has Paul Brady, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,005,212 in general payments to Paul Brady, MD across 871 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paul Brady, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paul Brady, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paul Brady, MD

Orthopaedic Surgery · Knoxville, TNNPI 1760468128

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $19,254,817 of the $20,005,212 with a category attached, or 96.2%. Arthrex accounts for 100.0% of it on its own, with 19 other manufacturers making up the rest. 2025 is the largest year on record at $6,145,755, 6.4 times the $967,126 reported in 2019. Among orthopaedic surgery clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,005,212in general payments, 2019–2025

Across 871 payments — averaging $22,968 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$20M
Alpha Orthopedic Systems$2K
Smith+Nephew$395
Smoky Mountain Surgical LLC$333
Ferring Pharmaceuticals Inc.$260
Radius Health, Inc.$155
plus $638 from 14 others

$116,949in research payments, 2019–2025

Across 19 payments — averaging $6155.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$117K

What the payments were for

Royalty or licence$19,254,81796%
Consulting fees$206,4151%
Speaking & faculty fees$462,5532%
Travel & lodging$68,1330%
Food & beverage$12,0940%
Education$1,2000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	801	$20,001,446
Alpha Orthopedic Systems	11	$1,985
Smith+Nephew	7	$395
Smoky Mountain Surgical LLC	3	$333
Ferring Pharmaceuticals Inc.	17	$260
Radius Health, Inc.	6	$155
Stryker	1	$144
Gemini Medical LLC	1	$123
Amgen(2 entities)	7	$103
Vertex	3	$63
Pacira Pharmaceuticals Incorporated	2	$38
Mid-atlantic Surgical Systems, LLC	1	$33
Johnson & Johnson(2 entities)	2	$30
DJO, LLC	1	$21
C. R. Bard, Inc. & Subsidiaries	1	$19
Davol Inc.	1	$17
Innovation Technologies Inc	1	$17
Sanara Medtech Inc.	3	$14
Kowa Pharmaceuticals America, Inc.	1	$12
Kinex Medical Company LLC	1	$5

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$84,246,473
SHOULDER IMPLANTS SUTURETAKS KNOTLESS$1,735,539
SHOULDER IMPLANTS OTHER AC JOINT REPAIR$1,735,539
KNEE & HIP IMPLANTS SUSPENSORY FIXATION ACL TIGHTROPE$1,735,539
SHOULDER IMPLANTS FIBERTAK KNOTLESS$1,533,313
SHOULDER SUTURE FIBERWIRE CERCLAGE$1,333,919
SHOULDER IMPLANTS CORKSCREWS KNOTLESS$603,845
CAPITAL CONSUMABLES CONSUMABLES BLADES & BURRS S BLADES & BURRS$1,950
SHOULDER SUTURE FIBERWIRE OTHER$325
ARTHROPLASTY INSTRUMENTS KNEE & HIP ARTHROPLASTY SPORTKNEE$228
CAPITAL CONSUMABLES CONSUMABLES RF BRF$163
1788$144
Regeneten$115
AETOS Shoulder System$114

How this compares

$20,005,212 in reported general payments places this provider in the 95th percentile of 381 orthopaedic surgery providers in Tennessee.

See all orthopaedic surgery providers in Tennessee →

Medicare billing

Part B allowed, 2024

$237,941

Medicare patients

613

Services billed

3,096

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron OdtOndansetron	18	$220
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	17	$123
Amoxicillin	88	$122
Celecoxib	11	$107
Meloxicam	22	$58
Tramadol Hcl	14	$29

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Knoxville

Edwin SpencerKnoxville$2.5M
Paul NaylorKnoxville$184K
George HollowayKnoxville$124K
Harold CatesKnoxville$106K
Adam ShortKnoxville$87K
Brian EdkinKnoxville$60K
Austin DavidsonKnoxville$56K
Benjamin WeisenthalKnoxville$52K
Jesse DotyChattanooga$2.3M
Thomas ThrockmortonGermantown$1.7M

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →